nach oben

The European Journal of Health Economics

Erschienen in:

26.08.2019 | Original Paper

Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review

verfasst von: Donghoon Lee, Ye-Rin Lee, In-Hwan Oh

Erschienen in: The European Journal of Health Economics | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

This systematic review examined the characteristics of published cost-effectiveness analyses of inpatient smoking cessation programs and assessed the methodological quality of the selected studies, to provide policymakers with economic evidence for this type of program.

Methods

A literature search was undertaken using a relevant database by three investigators. Only full economic evaluations with results in the form of the incremental cost-effectiveness ratio (ICER) were included. Costs were adjusted to 2016 US dollars using the Gross Domestic Product deflator and purchasing power parities. The British Medical Journal checklist was utilized to appraise the methodological quality of the included studies.

Results

Nine articles were ultimately selected. The inpatient smoking cessation programs appeared to be a highly cost-effective intervention according to the recommended cost-effectiveness thresholds by the World Health Organization or individual studies. The highest ICERs among the selected studies were $5593 per additional quit, $10,550 per life year gained, and $5680 per quality-adjusted life year gained.

Conclusions

This study provides robust evidence supporting the cost-effectiveness of smoking cessation programs for hospitalized patients. In addition, the results indicated that the degree of cost-effectiveness of the inpatient smoking cessation program might not be related to either the components of the program or methodological variations in the cost-effectiveness analysis. Policymakers should provide hospitals with resources and strong incentives to promote wider implementation of the smoking cessation program.

Nur mit Berechtigung zugänglich

National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention, Atlanta (2014)

Gronkjaer, M., Eliasen, M., Skov-Ettrup, L.S., Tolstrup, J.S., Christiansen, A.H., Mikkelsen, S.S., Becker, U., Flensborg-Madsen, T.: Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann. Surg. 259, 52–71 (2014). https://doi.org/10.1097/SLA.0b013e3182911913 CrossRefPubMed

Kroon, L.A.: Drug interactions with smoking. Am. J. Heal. Pharm. 64, 1917–1921 (2007). https://doi.org/10.2146/ajhp060414 CrossRef

Rigotti, N.A., Munafo, M.R., Stead, L.F.: Smoking cessation interventions for hospitalized smokers: a systematic review. Arch. Intern. Med. 168, 1950–1960 (2008)CrossRef

Rigotti, N.A., Clair, C., Munafò, M.R., Stead, L.F.: Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst. Rev. 5, CD001837 (2012). https://doi.org/10.1002/14651858.cd001837.pub3 CrossRefPubMedCentral

Ekpu, V.U., Brown, A.K.: The economic impact of smoking and of reducing smoking prevalence: review of evidence. Tob. Use Insights. 8, 1–35 (2015). https://doi.org/10.4137/TUI.S15628 CrossRefPubMedPubMedCentral

Garber, A. M. Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Aff. Suppl Web:W4-284–296 (2004). https://doi.org/10.1377/hlthaff.w4.284 CrossRef

National Institute for Health and Care Excellence: Smoking cessation in secondary care: cost-effectiveness review. https://www.nice.org.uk/guidance/ph48/evidence/review-of-cost-effectiveness-pdf-430365277. Accessed 10 Oct 2018

Drummond, M.F., Jefferson, T.O.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 313(7052), 275–283 (1996). https://doi.org/10.1136/bmj.313.7052.275 CrossRefPubMedPubMedCentral

10.

Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009). https://doi.org/10.1136/bmj.b2700 CrossRefPubMedPubMedCentral

11.

Centre for Reviews and Dissemination: Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care. CRD University of York, York (2008)

12.

Glanville, J., Fleetwood, K., Yellowlees, A., Kaunelis, D., Mensinkai, S.: Development and Testing of Search Filters to Identify Economic Evaluations in MEDLINE and EMBASE. Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa (2009)

13.

Neyt, M., Chalon, P.X.: Search MEDLINE for economic evaluations: tips to translate an OVID strategy into a PubMed one. Pharmacoeconomics. 31(12), 1087–1090 (2013). https://doi.org/10.1007/s40273-013-0103-0 CrossRefPubMed

14.

Richardson, W.S., Wilson, M.C., Nishikawa, J., Hayward, R.S.: The well-built clinical question: a key to evidence-based decisions. ACP J. Club 123(3), A12–A13 (1995)PubMed

15.

The World Bank: Inflation, GDP deflator (annual %). https://data.worldbank.org/indicator/NY.GDP.DEFL.KD.ZG. Accessed 14 Feb 2018

16.

Organisation for Economic Co-operation and Development (OECD): Purchasing power parities for GDP and related indicators. https://data.oecd.org/conversion/purchasing-power-parities-ppp.htm. Accessed 14 Feb 2018

17.

Chiou, C.-F., Hay, J.W., Wallace, J.F., Bloom, B.S., Neumann, P.J., Sullivan, S.D., Yu, H.T., Keeler, E.B., Henning, J.M., Ofman, J.J.: Development and validation of a grading system for the quality of cost-effectiveness studies. Med. Care 41(1), 32–44 (2003). https://doi.org/10.1097/01.MLR.0000039824.73620.E5 CrossRefPubMed

18.

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J., Loder, E., ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 16(2), 231–250 (2013). https://doi.org/10.1016/j.jval.2013.02.002 CrossRefPubMed

19.

Evers, S., Goossens, M., de Vet, H., van Tulder, M., Ament, A.: Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int. J. Technol. Assess. Health Care 21(2), 240–245 (2005)CrossRef

20.

Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., Glanville, J.: Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol. Assess. 8(36), 1–158 (2004)CrossRef

21.

Krumholz, H.M., Cohen, B.J., Tsevat, J., Pasternak, R.C., Weinstein, M.C.: Cost-effectiveness of a smoking cessation program after myocardial infarction. J. Am. Coll. Cardiol. 22(6), 1697–1702 (1993)CrossRef

22.

Croghan, I.T., Offord, K.P., Evans, T.W., Schmidt, S., Gomez-Dahl, L.C., Schroeder, D.R., Patten, C.A., Hurt, R.D.: Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience. Mayo Clin. Proc. 72(10), 917–924 (1997)CrossRef

23.

Meenan, R.T., Stevens, V.J., Hornbrook, M.C., La Chance, P.A., Glasgow, R.E., Hollis, J.F., Lichtenstein, E., Vogt, T.M.: Cost-effectiveness of a hospital-based smoking cessation intervention. Med. Care 36(5), 670–678 (1998)CrossRef

24.

Prathiba, B.V., Tjeder, S., Phillips, C., Campbell, I.A.: A smoking cessation counsellor: should every hospital have one? J. R. Soc. Promot. Health. 118(6), 356–359 (1998)CrossRef

25.

Quist-Paulsen, P., Lydersen, S., Bakke, P.S., Gallefoss, F.: Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 13(2), 274–280 (2006)CrossRef

26.

Ladapo, J.A., Jaffer, F.A., Weinstein, M.C., Froelicher, E.S.: Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction. Arch. Intern. Med. 171(1), 39–45 (2011)CrossRef

27.

Mullen, K.-A., Coyle, D., Manuel, D., Nguyen, H.V., Pham, B., Pipe, A.L., Reid, R.D.: Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada. Tob. Control 24(5), 489–496 (2015). https://doi.org/10.1136/tobaccocontrol-2013-051483 CrossRefPubMed

28.

Barnett, P.G., Wong, W., Jeffers, A., Hall, S.M., Prochaska, J.J.: Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial. J. Clin. Psychiatry 76(10), e1285–e1291 (2015). https://doi.org/10.4088/JCP.14m09016 CrossRefPubMedPubMedCentral

29.

Berndt, N., Bolman, C., Lechner, L., Max, W., Mudde, A., de Vries, H., Evers, S.: Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease. Eur. J. Health Econ. 17(3), 269–285 (2016). https://doi.org/10.1007/s10198-015-0677-x CrossRefPubMed

30.

Taylor, C., Houston-Miller, N., Killen, J.D., DeBusk, R.F.: Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention. Ann. Intern. Med. 113(2), 118–123 (1990)CrossRef

31.

Franke, D.L., Leistikow, B.N., Offord, K.P., Schmidt, L., Hurt, R.D.: Physician referrals for smoking cessation: outcome in those who show and don’t show. Prev. Med. (Baltim) 24(2), 194–200 (1995). https://doi.org/10.1006/pmed.1995.1033 CrossRef

32.

Hatziandreu, E.J., Pierce, J.P., Lefkopoulou, M., Lefkopoulou, M., Fiore, M.C., Mills, S.L., Novotny, T.E., Giovino, G.A., Davis, R.M.: Quitting smoking in the United States in 1986. J. Natl. Cancer Inst. 82(17), 1402–1406 (1990)CrossRef

33.

Hurt, R.D., Offord, K.P., Hepper, N.G.G., Mattson, B.R., Toddie, D.A.: Long-term follow-up of persons attending a community-based smoking-cessation program. Mayo Clin. Proc. 63(7), 681–690 (1988). https://doi.org/10.1016/S0025-6196(12)65530-X CrossRefPubMed

34.

Hurt, R.D., Dale, L.C., Fredrickson, P.A., Caldwell, C.C., Lee, G.A., Offord, K.P., Lauger, G.G., Marŭsić, Z., Neese, L.W., Lundberg, T.G.: Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA. 271(8), 595–600 (1994)CrossRef

35.

Stevens, V.J., Glasgow, R.E., Hollis, J.F., Lichtenstein, E., Vogt, T.M.: A smoking-cessation intervention for hospital patients. Med. Care 31(1), 65–72 (1993)CrossRef

36.

British Thoracic Society: Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Report by a subcommittee of the Research Committee of the British Thoracic Society. BMJ. 286(6365), 595–597 (1983)CrossRef

37.

British Thoracic Society: Smoking cessation in patients: two further studies by the British Thoracic Society. Research Committee of the British Thoracic Society. Thorax. 45(11), 835–840 (1990)CrossRef

38.

Quist-Paulsen, P., Gallefoss, F.: Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. BMJ 327(7426), 1254–1257 (2003). https://doi.org/10.1136/bmj.327.7426.1254 CrossRefPubMedPubMedCentral

39.

Eisenberg, M.J., Filion, K.B., Yavin, D., Bélisle, P., Mottillo, S., Joseph, L., Gervais, A., O’Loughlin, A., Paradis, G., Rinfret, S., Pilote, L.: Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 179(2), 135–144 (2008)CrossRef

40.

Reid, R.D., Mullen, K.A., Slovinec D’Angelo, M.E., Aitken, D.A., Papadakis, S., Haley, P.M., McLaughlin, C.A., Pipe, A.L.: Smoking cessation for hospitalized smokers: an evaluation of the “Ottawa Model”. Nicotine Tob. Res. 12(1), 11–18 (2010). https://doi.org/10.1093/ntr/ntp165 CrossRefPubMed

41.

World Health Organization: Macroeconomics and Health: Investing in Health for Economic Development: Report of the Commission on Macroeconomics and Health. WHO, Geneva (2001)

42.

Schwarzer, R., Rochau, U., Saverno, K., Jahn, B., Bornschein, B., Muehlberger, N., Flatscher-Thoeni, M., Schnell-Inderst, P., Sroczynski, G., Lackner, M., Schall, I.: Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J. Comput. Eff. Res. 4, 485–504 (2015)CrossRef

43.

EuroQol Group: EuroQol–a new facility for the measurement of health-related quality of life. Health Policy (New York) 16, 199–208 (1990)CrossRef

44.

Weinstein, M.C., Siegel, J.E., Gold, M.R., Kamlet, M.S., Russell, L.B.: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276, 1253–1258 (1996)CrossRef

45.

Sharpe, T., Alsahlanee, A., Ward, K.D., Doyle, F.: systematic review of clinician-reported barriers to provision of smoking cessation interventions in hospital inpatient settings. J. Smok. Cessat. 13, 233–243 (2018)CrossRef

46.

Fiore, M.C., Goplerud, E., Schroeder, S.A.: The joint commission’s new tobacco-cessation measures—Will hospitals do the right thing? N. Engl. J. Med. 366, 1172–1174 (2012)CrossRef

47.

Barua, R.S., Rigotti, N.A., Benowitz, N.L., Cummings, K.M., Jazayeri, M.A., Morris, P.B., Ratchford, E.V., Sarna, L., Stecker, E.C., Wiggins, B.S.: 2018 ACC expert consensus decision pathway on tobacco cessation treatment: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 72, 3332–3365 (2018)CrossRef

Titel: Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review
verfasst von: Donghoon Lee
Ye-Rin Lee
In-Hwan Oh
Publikationsdatum: 26.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: The European Journal of Health Economics / Ausgabe 9/2019
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-019-01105-7

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Funding orphan medicinal products beyond price: sustaining an ecosystem

Modest risk-sharing significantly reduces health plans’ incentives for service distortion

Health state utility values (QALY weights) for Huntington’s disease: an analysis of data from the European Huntington’s Disease Network (EHDN)

The effect of economic growth on obesity for the most obese countries: new evidence from the obesity Kuznets curve

Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

Ex-post moral hazard in the health insurance market: empirical evidence from German data